1. Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity

   • C. J. Sanchez
   • T. Le Treut
   • R. T. Costello

   Review 10 August 2010 Pages: 1 - 13

2. Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond

   • C. M. Britten
   • S. Janetzki
   • M. M. Davis

   Position paper Open access 16 November 2010 Pages: 15 - 22

   

3. MAGE-A3 and MAGE-A4 specific CD4⁺ T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes

   • Valérie Cesson
   • Jean-Paul Rivals
   • Pedro Romero

   Original Article 21 September 2010 Pages: 23 - 35

   

4. Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation

   • Willemijn van den Ancker
   • Marvin M. van Luijn
   • Arjan A. van de Loosdrecht

   Original Article Open access 22 September 2010 Pages: 37 - 47

   

5. Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells

   • Max Warncke
   • Maike Buchner
   • Hendrik Veelken

   Original Article Open access 17 September 2010 Pages: 49 - 60

   

6. Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers

   • Lei Wu
   • Anastasia Parton
   • J. Blake Bartlett

   Original Article 17 September 2010 Pages: 61 - 73

   

7. Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia

   • Franz Josef Gassner
   • Lukas Weiss
   • Inge Tinhofer

   Original Article Open access 21 September 2010 Pages: 75 - 85

   

8. An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine

   • R. Curtis Bird
   • Patricia DeInnocentes
   • Bruce F. Smith

   Original Article 11 November 2010 Pages: 87 - 97

   

9. Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model

   • Hidenobu Ishizaki
   • Edwin R. Manuel
   • Joshua D. I. Ellenhorn

   Original Article 20 October 2010 Pages: 99 - 109

   

10. Receptor desensitization and blockade of the suppressive effects of prostaglandin E₂ and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes

    • Yunyun Su
    • Edwin K. Jackson
    • Elieser Gorelik

    Original Article 20 October 2010 Pages: 111 - 122

    

11. Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival

    • A. N. Cornforth
    • A. W. Fowler
    • R. O. Dillman

    Original Article 20 October 2010 Pages: 123 - 131

    

12. Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells

    • Timothy J. Haggerty
    • Ian S. Dunn
    • James T. Kurnick

    Original Article 30 October 2010 Pages: 133 - 144

    

13. CD4⁺ T cell response against a non-tumor antigen is unaffected in melanoma-bearing mice

    • Ana Paula Duarte de Souza
    • Thiago de Jesus Borges
    • Cristina Bonorino

    Short communication 21 October 2010 Pages: 145 - 151